The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...

ADT speeds coronary atherosclerosis, with greater effects with use of the GnRH-agonist leuprolide compared with the GnRH-antagonist relugolix. Coronary atherosclerosis may progress more over 12 months ...

LUPRON DEPOT-3 MONTH 11.25mg prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

A McGill University research team has developed a painless, automated way to deliver in vitro fertilization (IVF) hormones ...